Introduction: built-in chromatographic, free of charge payload, and cytotoxicity assays enable exact DAR characterization vital to optimizing Secure and productive antibody-drug conjugates in cancer therapy. while in the realm of specific most cancers therapies, retaining arduous top quality standards is vital, especially regarding drug-to-antibod